Literature DB >> 2348426

Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis.

M M Ward1, S Studenski.   

Abstract

The influence of age on the prevalence of individual clinical manifestations of systemic lupus erythematosus (SLE) has not been adequately distinguished from racial or gender influences. Therefore, we examined variations in the clinical manifestations of SLE with age in a group of 361 patients. Multivariate regression techniques, including logistic regression and analysis of covariance, were used to identify clinical features associated with age, while controlling for important confounding factors, including race, gender, duration of followup, and treatment effects. Lymphopenia was found more frequently with increasing age, while malar rash, seizures, false-positive VDRL, thrombocytopenia (in whites), proteinuria (0.5-3.5 g/day), elevated antidouble stranded DNA antibodies, and hypocomplementemia were found less frequently. No age relationship was found for the prevalence of 16 of 24 clinical features examined, including the important disease manifestations of arthritis, serositis, psychosis, nephrotic-range proteinuria, renal failure, autoimmune hemolytic anemia, and leukopenia. The use of regression analysis allows the recognition of similarities and differences in cumulative clinical features of SLE due to age in isolation from the effects of other demographic factors.

Entities:  

Mesh:

Year:  1990        PMID: 2348426

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Systemic lupus erythematosus arising in a patient with chronic silicosis.

Authors:  K Ozoran; H Uçan; H Tutkak; N Caner; M Yücel
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

Review 4.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

5.  An uncommon cause of fever in the elderly: late-onset systemic lupus erythematosus.

Authors:  Esin Beyan; Aysel Uzuner; Cengiz Beyan
Journal:  Clin Rheumatol       Date:  2003-11-07       Impact factor: 2.980

6.  Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.

Authors:  N D Hopkinson; M Doherty; R J Powell
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

7.  The influence of aging on the induction and manifestations of experimental systemic lupus erythematosus.

Authors:  R Segal; A Globerson; H Zinger; E Mozes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

8.  Presentation of SLE in UK primary care using the Clinical Practice Research Datalink.

Authors:  Alison L Nightingale; Julie E Davidson; Charles T Molta; Hong J Kan; Neil J McHugh
Journal:  Lupus Sci Med       Date:  2017-02-10

Review 9.  The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus.

Authors:  Titilola Falasinnu; Yashaar Chaichian; Michelle B Bass; Julia F Simard
Journal:  Curr Rheumatol Rep       Date:  2018-03-17       Impact factor: 4.592

10.  [Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study].

Authors:  Fatima Zahra Ha-ou-nou; Lamiaa Essaadouni
Journal:  Pan Afr Med J       Date:  2015-05-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.